Three Bridge Wealth Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$194K Buy
+6,666
New +$177K 0.04% 95

Other funds holding AMLX

Three Bridge Wealth Advisors's AMLX Position: Q3 2026 in Review

Three Bridge Wealth Advisors opened a new position in Amylyx Pharmaceuticals (AMLX) in Q3 2026: 6,666 shares worth $194K. The stake represents 0.04% of the portfolio and ranks #95 among its holdings.

230 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.

  • Three Bridge Wealth Advisors held 6,666 shares of Amylyx Pharmaceuticals worth $194K as of Q3 2026.
  • Amylyx Pharmaceuticals was a new Three Bridge Wealth Advisors position in Q3 2026.
  • Amylyx Pharmaceuticals made up 0.04% of Three Bridge Wealth Advisors's portfolio in Q3 2026, its #95 holding.
  • 230 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.

Based on Three Bridge Wealth Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.